Multiple sclerosis outcomes after cancer immunotherapy

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Catherine R GarciaJohn L Villano

Abstract

Neurological immune-related adverse events are a rare but potentially deadly complication after immune checkpoint inhibitor (ICI) treatment. As multiple sclerosis (MS) is an immune-mediated disease, it is unknown how ICI treatment may affect outcomes. We analyzed the United States Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) database for pembrolizumab, atezolizumab, nivolumab, ipilimumab, avelumab, and durvalumab 2 years prior their FDA approval until December 31, 2017, to include all cases with confirmed diagnosis/relapse of MS. We also included cases reported in the literature and a patient from our institution. We identified 14 cases of MS with median age of presentation of 52 years. Indications for ICI included melanoma in 7 (36.36%) cases, non-small cell lung carcinoma in 2 (18.18%) cases, 1 case (9.09%) each of pleural mesothelioma, renal cell carcinoma, and colorectal cancer, and unreported in 2 (18.18%) cases. History of MS was confirmed in 8 (57.1%) cases. Median time to beginning of symptoms was 29 days with rapid disease progression; two patients died due to their relapse. Median time for symptom resolution was 8 weeks. Outcomes did not vary by comparing CTLA-4 and PD-1/PD-L1 inhibitors. ...Continue Reading

References

Aug 1, 1981·Clinical Pharmacology and Therapeutics·C A NaranjoD J Greenblatt
Sep 28, 2000·The New England Journal of Medicine·J H NoseworthyB G Weinshenker
Oct 13, 2004·Archives of Neurology·Howard L Weiner
Aug 17, 2010·Journal of Autoimmunity·Yehuda Shoenfeld, Nancy Agmon-Levin
Mar 29, 2011·Neurologic Clinics·Sreeram V Ramagopalan, A Dessa Sadovnick
Sep 8, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Serena S KwekLawrence Fong
Jun 26, 2013·International Journal of Medical Sciences·Toshiyuki SakaedaYasushi Okuno
Apr 29, 2014·Annals of Neurology·Imke MetzClaudia F Lucchinetti
Sep 27, 2014·Multiple Sclerosis : Clinical and Laboratory Research·Edward J GettingsThomas F Scott
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertPaolo A Ascierto
Nov 20, 2014·The New England Journal of Medicine·Alexandra SnyderTimothy A Chan
Dec 9, 2014·The New England Journal of Medicine·Stephen M AnsellPhilippe Armand
Mar 27, 2015·PloS One·Gianmauro NumicoNicola Silvestris
Apr 22, 2015·The New England Journal of Medicine·Caroline RobertUNKNOWN KEYNOTE-006 investigators
Apr 22, 2015·The New England Journal of Medicine·Edward B GaronUNKNOWN KEYNOTE-001 Investigators
Jun 2, 2015·The New England Journal of Medicine·James LarkinJedd D Wolchok
Jun 2, 2015·The New England Journal of Medicine·Julie BrahmerDavid R Spigel
Sep 26, 2015·The New England Journal of Medicine·Robert J MotzerUNKNOWN CheckMate 025 Investigators
Sep 29, 2015·The New England Journal of Medicine·Hossein BorghaeiJulie R Brahmer
Apr 17, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Lisa ZimmerLucie M Heinzerling
Apr 27, 2016·Seminars in Neurology·Alberto Ascherio, Kassandra L Munger
Jun 29, 2016·Annals of Neurology·Lisa Ann GerdesReinhard Hohlfeld
Jan 9, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S CuzzubboA F Carpentier
Apr 5, 2017·Journal of the National Cancer Institute·James L GulleyCharles G Drake
Apr 21, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L SpainJ Larkin
Jun 2, 2017·Continuum : Lifelong Learning in Neurology·W Oliver Tobin, Sean J Pittock
Sep 6, 2017·JAMA Neurology·Justin C KaoMichelle L Mauermann
Sep 9, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J B A G HaanenUNKNOWN ESMO Guidelines Committee
Oct 11, 2017·Neuro-oncology·Alicia M Zukas, David Schiff
Jan 11, 2018·The New England Journal of Medicine·Michael A PostowMatthew D Hellmann
Jan 15, 2018·Journal of Neuro-oncology·Avi FellnerShlomit Yust-Katz
Jan 20, 2018·Alimentary Pharmacology & Therapeutics·L HarinsteinA Brinker
Aug 15, 2018·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Ouidad ZehouCéleste Lebbé
Jul 1, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J B A G HaanenUNKNOWN ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

❮ Previous
Next ❯

Citations

Oct 6, 2019·Journal of Neurology·Marzia Anita Lucia RomeoMassimo Filippi
Mar 4, 2020·Expert Opinion on Drug Safety·Alexandra M HaughDouglas B Johnson
Aug 20, 2019·ESMO Open·Lavinia SpainSamra Turajlic
Aug 18, 2020·Cancer Immunology, Immunotherapy : CII·Omar Hasan AliLukas Flatz
Sep 8, 2020·Asia-Pacific Journal of Clinical Oncology·Siyuan FanHongzhi Guan
Apr 10, 2020·Nature Reviews. Immunology·Liliana E Lucca, Margarita Dominguez-Villar
Jun 4, 2020·Continuum : Lifelong Learning in Neurology·Bianca D Santomasso
Jul 15, 2020·European Journal of Clinical Pharmacology·Francesca CaputoDamiano Paolicelli
Dec 29, 2020·Frontiers in Neurology·Marcos C B OliveiraMateus M Simabukuro
Dec 11, 2020·The Cancer Journal·Mitchell S von ItzsteinDavid E Gerber
Nov 15, 2020·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Elia Sechi, Anastasia Zekeridou
Apr 5, 2021·Journal of the Neurological Sciences·Cecilia Zivelonghi, Anastasia Zekeridou
May 27, 2021·Current Neurology and Neuroscience Reports·Amy A Pruitt
Aug 24, 2021·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Luca DiamantiEnrico Marchioni
Jan 14, 2022·The Journal of Immunology : Official Journal of the American Association of Immunologists·Britta E JonesJane H Buckner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.